Lantern Pharma Reports Third Quarter 2024 Financial Results and Business Updates

Go back to Lantern Pharma Reports Third Quarter 2024 Financial Results and Business Updates
(NASDAQ: LTRN) Delayed: 3.88 +0.09 (2.37%)
Previous Close $3.79    52 Week High
Open $3.84    52 Week Low
Day High $4.10    P/E N/A 
Day Low $3.77    EPS
Volume 104,334